-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

908.O2.3 908. Outcomes Research: Myeloid Malignancies: Identifying Problems and Providing Solutions to Delivering Myeloid Malignancy Care

Symposia: Outcomes Research: Myeloid Malignancies Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Research, MDS, Adult, AML, Acute Myeloid Malignancies, Clinical Practice (Health Services and Quality), Epidemiology, Workforce, Clinical Research, Health outcomes research, Diversity, Equity, and Inclusion (DEI), Pediatric, Supportive Care, Diseases, Patient-reported outcomes, Real-world evidence, Treatment Considerations, Young adult , Registries, Myeloid Malignancies, Study Population, Human, Transfusion, Measurable Residual Disease
Saturday, December 7, 2024: 9:30 AM-11:00 AM
Grand Hall C (Manchester Grand Hyatt San Diego)
Moderators:
Nandita Khera, MD, Mayo Clinic and Brittany Knick Ragon, MD, Levine Cancer Institute
Disclosures:
Ragon: Genentech: Consultancy, Other: Advisory Board ; Pfizer: Consultancy, Other: Advisory Board ; Astellas: Consultancy, Other: Advisory Board; Syndax: Consultancy, Other: Advisory Board.
9:30 AM

Tine Bichel Lauritsen, MD, PhD1*, Dennis Lund Hansen, MD, PhD2*, Jan M Norgaard, MD, PhD, DMSc1, Susanne Dalton, MD, DMSc, Prof3,4*, Kirsten Gronbaek, MD, PhD, PR5,6, Tarec Christoffer El-Galaly, MD, DMSc, Prof2,7,8 and Lene Sofie Granfeldt Østgård2,9*

1Department of Hematology, Aarhus University Hospital, Aarhus, Denmark
2Department of Hematology, Odense University Hospital, Odense, Denmark
3Department of Clinical Oncology and Palliative Care, Zealand University Hospital, Næstved, Denmark
4Cancer Survivorship, Danish Cancer Institute, Danish Cancer Society Research Center, Copenhagen, Denmark
5Rigshospitalet, University of Copenhagen, Copenhagen N, Denmark
6Department of Hematology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark
7Department of Clinical Medicine, Aalborg University, Aalborg, Denmark
8Department of Hematology, Aalborg Hospital, Aalborg, Denmark
9Aarhus University Hospital, Department of Clinical Epidemiology, Aarhus, Denmark

9:45 AM

Daniel J. Zheng, MD1, Gary Hettinger, MS2*, Lusha Cao, PhD, MS3*, Caitlin W. Elgarten, MD1*, Brian T. Fisher, DO, MPH, MSCE2,4*, Cody Gathers, MD, MSHP5*, Yuan-Shung V. Huang, MS3*, Jennifer Ko2*, Kasey Leger, MD, MSc6, Yimei Li, PhD1,2*, Regina M. Myers, MD1, Hari K. Narayan7*, Jose Ortiz1,2*, Alix E. Seif, MD, MPH1, Richard Aplenc1,8 and Kelly D. Getz, PhD2*

1Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, PA
2Department of Biostatistics, Epidemiology and Informatics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA
3Department of Biomedical and Health Informatics, Children's Hospital of Philadelphia, Philadelphia, PA
4Division of Infectious Diseases, Children's Hospital of Philadelphia, Philadelphia, PA
5Division of Cardiology, Children's Hospital of Philadelphia, Philadelphia, PA
6Division of Pediatric Hematology and Oncology, Seattle Children's Hospital, Seattle, WA
7Department of Pediatrics, University of California San Diego, La Jolla, CA
8Department of Biostatistics, Epidemiology, and Informatics, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA

10:00 AM

Areej El-Jawahri, MD1, Alison R Kavanaugh2*, Joseph A Greer, PhD2,3*, Vicki Jackson, MD2*, Jillian Gustin, MD4*, Alice Mims, MD5, Albert Cook, MD6*, Thomas W. LeBlanc, MD, MA, MS7, Amir T. Fathi, MD8, Gabriela S. Hobbs, MD9, Andrew M. Brunner, MD10 and Jennifer S Temel2*

1Massachusetts General Hospital, Allston, MA
2Massachusetts General Hospital, Boston, MA
3Harvard Medical School, Boston, MA
4Palliative Care, Ohio State Univeristy, Columbus, OH
5The Ohio State University Comprehensive Cancer Center, Columbus, OH
6Palliative Care, The Ohio State University, Columbus, OH
7Duke Cancer Institute, Hillsborough, NC
8Center for Leukemia, Massachusetts General Hospital Cancer Center, Boston, MA
9Division of Hematology/Oncology, Massachusetts General Hospital, Boston, MA
10Division of Hematology/Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA

10:15 AM

Maria Diez-Campelo, MD, PhD1*, Sophie Park, MD, PhD2, Tracey Iraca3*, Mrudula B. Glassberg4*, Marc DeCongelio5*, Alison Bulkley5*, Abisola Olopoenia5*, Jennifer Lord-Bessen6*, Grace Skiles5*, Katie Aguinaga5*, Neelanzana Paudel5*, Oliver Will5*, Dimana Miteva7*, Christina Hughes8*, Ahmed Hnoosh9* and Aylin Yucel8*

1Institute of Biomedical Research of Salamanca, University Hospital of Salamanca, Salamanca, Spain
2Grenoble Alpes University, Grenoble Alpes University Hospital, Hematology Department, Grenoble, France
3The Myelodysplastic Syndromes Foundation, Yardville, NJ
4Bristol Myers Squibb, Madison, NJ
5Oracle Life Sciences, Austin, TX
6Bristol Myers Squibb, Lawrenceville, NJ
7Celgene International Sàrl, a Bristol-Myers Squibb Company, Boudry, Switzerland
8Bristol Myers Squibb, Princeton, NJ
9Bristol Myers Squibb, Uxbridge, United Kingdom

10:30 AM

Roberta Demichelis, MD1, Gilberto Israel Barranco Lampón, MD2*, Carlos Madrigal-Iberri3*, Marlén K Sánchez-Peña, MD4*, Maripaz Márquez, PhD, MBA4*, Akemi Ishikawa5*, Zhere Derian Garcia-Trujillo, MSc6* and Raúl Martinez Castro, MD7*

1Hematology and Oncology Department, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico
2Hematology Department, General Hospital of Mexico “Dr. Eduardo Liceaga”, Mexico City. Mexico., Mexico City, EM, Mexico
3Medical and Patient Affairs Department, Servier Mexico, Mexico City, Mexico
4Servier Mexico, Mexico City, Mexico
5Pan-International CREEK Study Project Lead/Hematology Medical Manager, AstraZeneca Mexicoakemi, Mexico, Mexico
6Escuela Nacional de Ciencias Biológicas, Instituto Politécnico Nacional, Mexico City, Mexico
7Hematology Department, Hospital de Especialidades Centro Medico Nacional Siglo XXI, IMSS, CDMX, EM, Mexico

10:45 AM

Justin CT Loke, MD PhD1,2,3, Charlotte Gaskell, BSc MSc4*, Emily Yafai, BSc2*, Sonia Fox, BSc2*, Catherine Thomas, PhD, BSc2*, Louise Hopkins2*, Rebecca Boucher2*, Rebecca Collings2*, Steve Knapper, MRCP, FRCPath, DM5*, Anjum Khan6*, Jane Nunnick1*, Katie Randall7*, Jenny O'Nions8*, Tom Rider9*, Arpad Toth10*, Mary Frances McMullin, MD, FRCPath, FRCP11, Sally Moore12*, Victoria Drew13*, Farooq Ahmad Wandroo, MD, FRCPath, FRCP14*, Pratap Neelakantan15*, Pramila Krishnamurthy, MD16*, Charles Craddock, FRCP, FRCPath1,17, Sylvia Rofael18*, Vinit Upsani18*, David M Lowe18,19* and Simon J Stanworth, MA, FRCP (Paeds, UK), DPhil, FRCPath20,21,22*

1Queen Elizabeth Hospital, Birmingham, United Kingdom
2University of Birmingham, Birmingham, United Kingdom
3Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
4Cancer Research UK Trials Unit, University of Birmingham, Birmingham, United Kingdom
5Cardiff University School of Medicine, Cardiff, United Kingdom
6St James Hospital, Leeds, United Kingdom
7Warwick Hospital, Warwick, United Kingdom
8Department of Haematology, University College London Hospital, London, United Kingdom
9Brighton and Sussex University Hospitals NHS Trust, Brighton, United Kingdom
10Clatterbridge Cancer Centre, Liverpool, United Kingdom
11BHSCT, Belfast, United Kingdom
12University Hospitals Bristol and Weston, Bristol, United Kingdom
13Bradford Teaching Hospital, Bradford, United Kingdom
14Sandwell & West Birmingham Hospitals, NHS Trust, Birmingham, United Kingdom
15Royal Berkshire Hospital, Reading, United Kingdom
16Dept. of Haematological Medicine, King's College Hospital NHS Foundation Trust, London, United Kingdom
17University of Warwick, Coventry, United Kingdom
18University College London, London, United Kingdom
19Royal Free Hospital, London, United Kingdom
20Oxford University Hospitals, Oxford, United Kingdom
21NHS Blood and Transplant, Oxford, United Kingdom
22Department of Haematology, Oxford University, Oxford, United Kingdom

*signifies non-member of ASH